A chemoenzymatic approach toward the rapid and sensitive detection of O-GlcNAc posttranslational modifications.
about
Exploring the O-GlcNAc proteome: direct identification of O-GlcNAc-modified proteins from the brainGlycan Engineering for Cell and Developmental BiologySite-Specifically Labeled Immunoconjugates for Molecular Imaging--Part 1: Cysteine Residues and GlycansThe hexosamine signaling pathway: deciphering the "O-GlcNAc code"Enzymatic labeling of proteins: techniques and approachesRegulation of calcium/calmodulin-dependent kinase IV by O-GlcNAc modification.Direct identification of nonreducing GlcNAc residues on N-glycans of glycoproteins using a novel chemoenzymatic methodFold-recognition and comparative modeling of human alpha2,3-sialyltransferases reveal their sequence and structural similarities to CstII from Campylobacter jejuni.Site specific conjugation of fluoroprobes to the remodeled Fc N-glycans of monoclonal antibodies using mutant glycosyltransferases: application for cell surface antigen detectionO-GlcNAc protein modification in plants: Evolution and function.The role of O-GlcNAc signaling in the pathogenesis of diabetic retinopathy.Detection of 5-hydroxymethylcytosine in DNA by transferring a keto-glucose by using T4 phage β-glucosyltransferaseTools for Studying Glycans: Recent Advances in Chemoenzymatic Glycan LabelingEnrichment of O-GlcNAc modified proteins by the periodate oxidation-hydrazide resin capture approachChemoenzymatic synthesis of uridine 5'-diphospho-2-acetonyl-2-deoxy-alpha-D-glucose as C(2)-carbon isostere of UDP-GlcNAcQuantification of O-glycosylation stoichiometry and dynamics using resolvable mass tags.Mapping of O-GlcNAc sites of 20 S proteasome subunits and Hsp90 by a novel biotin-cystamine tag.Beta-N-acetylglucosamine (O-GlcNAc) is part of the histone codeAssignment of protein function in the postgenomic era.O-GlcNAcylation: a novel post-translational mechanism to alter vascular cellular signaling in health and disease: focus on hypertension.Z-band alternatively spliced PDZ motif protein (ZASP) is the major O-linked β-N-acetylglucosamine-substituted protein in human heart myofibrilsThe E2F-1 associated retinoblastoma-susceptibility gene product is modified by O-GlcNAc.Boronic acid-functionalized detonation nanodiamond for specific enrichment of glycopeptides in glycoproteome analysis.Improved synthesis of UDP-2-(2-ketopropyl)galactose and a first synthesis of UDP-2-(2-ketopropyl)glucose for the site-specific linking of biomolecules via modified glycan residues using glycosyltransferasesProteomic approaches for site-specific O-GlcNAcylation analysis.Chemical reporters for fluorescent detection and identification of O-GlcNAc-modified proteins reveal glycosylation of the ubiquitin ligase NEDD4-1Reversible hydrazide chemistry-based enrichment for O-GlcNAc-modified peptides and glycopeptides having non-reducing GlcNAc residues.Site-specific antibody-drug conjugates: the nexus of bioorthogonal chemistry, protein engineering, and drug developmentSite-specific antibody-drug conjugation through an engineered glycotransferase and a chemically reactive sugarChemical approaches to understanding O-GlcNAc glycosylation in the brain.The N-acetyl-binding pocket of N-acetylglucosaminyltransferases also accommodates a sugar analog with a chemical handle at C2.Role of a single amino acid in the evolution of glycans of invertebrates and vertebratesCross talk between O-GlcNAcylation and phosphorylation: roles in signaling, transcription, and chronic disease.The roles of O-linked β-N-acetylglucosamine in cardiovascular physiology and disease.Exploring kinase cosubstrate promiscuity: monitoring kinase activity through dansylation.Bioconjugation and detection of lactosamine moiety using alpha1,3-galactosyltransferase mutants that transfer C2-modified galactose with a chemical handle.Mutant glycosyltransferases assist in the development of a targeted drug delivery system and contrast agents for MRIGlycoproteomics enabled by tagging sialic acid- or galactose-terminated glycansApplications of glycosyltransferases in the site-specific conjugation of biomolecules and the development of a targeted drug delivery system and contrast agents for MRI.Use of novel mutant galactosyltransferase for the bioconjugation of terminal N-acetylglucosamine (GlcNAc) residues on live cell surface
P2860
Q24561943-6336BA12-B403-4A11-8228-04AB2B8DAA12Q26765063-25E89968-7282-4154-9E9D-AE7D1D53AFB9Q28078378-A8A86A90-75C6-4D55-8891-8098A440C397Q28284365-B7AA7B05-C9CF-47EB-9FBD-87F5FBE00E6EQ30351966-CA4C7CF2-668A-4798-915A-10674040A801Q30490721-8F2A25B5-972A-487E-A156-BD3AC20F928EQ30830469-A96DF14A-29EF-4A0F-B88D-603E5A2DBCBCQ33240177-45B68A63-67E9-462B-8749-92B8CD9D4BBBQ33441587-45CABE49-4786-421A-A7C8-B640416A3659Q33625578-EC4F0DFA-1DA8-401F-8140-2CB09EBA6157Q33683197-7DBEBA3F-D467-4B69-BE46-5C9ED31D5188Q33784531-33D98626-DC0F-4BFC-B485-3371E074F5DDQ33793649-53595BC1-0E35-4AC9-8CFF-C0EE7C53F0E1Q33835452-3FA50BAC-2F60-475C-A56D-52A221862764Q34048300-27DADFAA-F99E-4AB9-9AC7-84162584592BQ34075637-8926E894-DB01-4A3B-BD1E-09A391DFDBF9Q34255802-5C0D8553-B21E-4526-85B8-D5AFFAD37CC3Q34359019-1AA59029-459E-4B94-9417-D3BF559A7E47Q34483923-7389DF84-9A00-4318-A6E2-D826F0A74DD4Q34498193-7FF84736-BA42-4FA4-B423-230FEA3CFFBAQ34524429-CBC07A14-B472-4FA4-972F-224CDFBF8124Q34538240-3E69EF19-1587-4694-A800-9F9B44FC1C66Q34574366-FB28B0AA-89C6-4F9E-9A8A-88F2EE1DC5BEQ34703755-5171BF87-4153-45B1-B9FB-72D658E5BFE3Q34763872-E33987FF-3DBE-42AE-A347-B0E5DF7382D5Q35002612-BA2B1DB3-3F99-40D5-981E-18875048DF7DQ35018981-E1B1846C-07D8-4425-BBB7-C432DC1F2923Q35105725-D5321EEF-666A-4802-BF8F-8AF6451B1AAAQ35526950-2F230C40-C8BA-4DF4-BB6B-B13EF8F0379CQ35648339-BD93A03F-60FB-4244-A666-920DDBBC2BD5Q35703104-7A5D544A-3AF2-4972-A994-919EE5E61309Q35748282-799EB9E4-BF57-41AC-AFA5-6E977C7A250FQ35804446-7B06BE8A-70BF-4A96-B238-C2497AC95BA4Q35994096-855651AF-F311-4F3D-BB7F-0565496F5BDAQ36001163-C5D89DC4-F267-4661-88B0-F40B174FC414Q36298206-05E86BE2-17AD-4251-807A-7604EC5B6EF7Q36439174-97140E2B-F0C1-416E-A2CA-CAB7A48FC827Q36491781-422DC067-DE0C-4E2C-AB32-3FAB430A59ABQ36536065-9A4D139C-CD04-4BC7-BC04-6165088C7C49Q36540585-CCBF56F2-D3B9-44FA-953B-AD9F02F695A2
P2860
A chemoenzymatic approach toward the rapid and sensitive detection of O-GlcNAc posttranslational modifications.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
A chemoenzymatic approach towa ...... sttranslational modifications.
@en
A chemoenzymatic approach towa ...... sttranslational modifications.
@nl
type
label
A chemoenzymatic approach towa ...... sttranslational modifications.
@en
A chemoenzymatic approach towa ...... sttranslational modifications.
@nl
prefLabel
A chemoenzymatic approach towa ...... sttranslational modifications.
@en
A chemoenzymatic approach towa ...... sttranslational modifications.
@nl
P2093
P356
P1476
A chemoenzymatic approach towa ...... sttranslational modifications.
@en
P2093
Alexander Lippert
Boopathy Ramakrishnan
Katherine G Poulin-Kerstien
Linda C Hsieh-Wilson
Nathan Lamarre-Vincent
Nelly Khidekel
Pradman K Qasba
Sabine Arndt
P304
16162-16163
P356
10.1021/JA038545R
P407
P577
2003-12-01T00:00:00Z